Transmedics, INC.

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$3.2Mgeneral payments (2019-2025)
$760Kresearch payments (2019-2025)
662clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $0.00
2020 $0.00
2021 $371K
2022 $250K
2023 $1.1M
2024 $851K
2025 $629K

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Thoracic Surgery (Cardiothoracic Vascular Surgery) $798K
Surgery $630K
Pulmonary Disease $528K
Advanced Heart Failure and Transplant Cardiology $520K
Transplant Surgery $495K
Gastroenterology (Internal Medicine) $73K

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Marshall Hertz Minneapolis, MN Pulmonary Disease $289,090.21
Sean Pinney New York, NY Advanced Heart Failure and Transplant Cardiology $171,658.26
Carmelo Milano Lumberton, NC Thoracic Surgery (Cardiothoracic Vascular Surgery) $145,898.13
Maryjane Farr Dallas, TX Advanced Heart Failure and Transplant Cardiology $143,215.08
Josef Stehlik Salt Lake City, UT Advanced Heart Failure and Transplant Cardiology $143,202.31
Gabriel Loor Houston, TX Thoracic Surgery (Cardiothoracic Vascular Surgery) $100,439.00
David Cronin Roanoke, VA Surgery $88,952.90
Rafik Ghobrial Houston, TX Transplant Surgery $76,277.47
Samer Gawrieh Indianapolis, IN Gastroenterology (Internal Medicine) $72,000.00
Adam Bodzin Philadelphia, PA Transplant Surgery $71,353.37

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.